Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
1.080
+0.020 (1.89%)
At close: Aug 18, 2026, 4:00 PM EDT
1.090
+0.010 (0.93%)
After-hours: Aug 18, 2026, 4:58 PM EDT
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $74.28 million as of August 18, 2026. Its market cap has increased by 54.43% in one year.
Market Cap
74.28M
Enterprise Value
69.24M
1-Year Change
54.43%
Ranking
Category
Stock Price
$1.08
ChartMarket Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $74.28M, a decrease of -64.16%. That is a compound annual growth rate of -33.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 74.28M | 62.44% |
| Dec 31, 2025 | 45.73M | -62.70% |
| Dec 31, 2024 | 122.58M | -40.86% |
| Feb 9, 2024 | 207.27M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eloxx Pharmaceuticals | 74.55M |
| Annovis Bio | 74.02M |
| LeonaBio | 72.42M |
| iBio, Inc. | 72.03M |
| Rein Therapeutics | 71.96M |
| XBiotech | 70.43M |
| Cardiff Oncology | 70.35M |
| Cingulate | 70.17M |